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Introduction
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T cell-based immunotherapies have received great interest from clinicians and industry due to their potential to treat, 
Microcarriers produce higher frequencies of memory T cells and CD4+ T cells com-
93
pared to conventional microbeads 94 After observing differences in expansion, we further hypothesized that the carrier cultures could lead to a different 95 T cell phenotype. In particular, we were interested in the formation of memory T cells, as these represent a subset 96 with higher replicative potential and therefore improved clinical prognosis [20, 21] . We measured memory T cell 97 frequency staining for CCR7 and CD62L (both of which are present on lower differentiated T cells such as central Of additional interest to us was the preservation of the CD4 compartment. In healthy donor samples (such as 102 those used here), the typical CD4:CD8 ratio is 2:1. We noted that carriers produced a more balanced culture with 103 CD4 T cells at a higher frequency compared to bead cultures, which had nearly 90 % CD8 T cells (Fig. 2b) . While 104 both systems had a preference for expanding CD8 T cells, our results indicated that the carriers allow a better 105 CD4:CD8 ratio.
106
To test if this observation was consistent across experimental conditions, we pooled data for multiple T cells 107 expansions where these markers where measured on day 14; these experiments had varying conditions as well as 108 different donors (Table S7) , and thus the pooled dataset provided a test for robustness. Comparing beads and 109 carriers for both memory and CD4 T cell percentage, we noted that carriers provided a higher percentage in nearly 110 every case (Fig. 2c) . This trend was similar for both memory CD4+ and CD8+ subpopulations.
111
We analyzed this pooled dataset using linear regression analysis to determine if there was a significant difference 112 between the beads and carriers in either memory or CD4 phenotype (Tables S2 and S3 and Figs. S2a and S2b). In 113 both cases, the activation method (carrier vs. bead) was highly significant, with the carriers producing 13 % and 114 21 % greater frequencies of memory and CD4+ T cells respectively. The regression analysis also revealed that both 115 phenotypes depended highly on donor but not on any of the aggregate process parameters (total IL2, total added 116 glucose as calculated by the amount of media added, and the fold change of culture volume increase).
117
We also verified that expanded T cells were migratory using a chemotaxis assay for CCL21; since carriers produced 118 a larger percentage of memory T cells (which have CCR7, the receptor for CCL21) we would expect higher migration 119 in carrier-expanded cells vs. their bead counterparts. Indeed, we noted a significantly higher percentage of migration 120 in carriers and a dose-dependent response to CCL21 (Figs. 2d and S3 and Table S6 ).
121
Microcarriers require less IL2 for robust expansion compared to beads 122 We next asked if T cells required less exogenous IL2 in the carriers vs. traditional beads, as the initial hypothesis 123 for the design was that the macroporous structure would allow more efficient autocrine and paracrine signaling by 124 increasing local cell density. We expanded T cells using either beads or carriers for 14 d using varying amounts of 125 IL2 from 0 U/mL to 100 U/mL added every two days. Overall, we noted that the carriers expanded the T cells more 126 robustly (Fig. 3a) and required lower IL2 concentrations while maintaining equivalent expansion (Fig. 3b ). When (DOE) methodology, a technique commonly used to optimize complex manufacturing processes. We varied the IL2 134 concentration, the number of carriers, and the number of mAbs on the surface of the carriers. Since we desired to 135 understand non-linear influence of these variables, we chose three levels for each (10, 20 and 30 U/mL for IL2; 500, 136 1500 and 2500 carriers/mL for carrier concentration; 60, 80 and 100 % surface coverage for mAb surface density). Note 137 that in the case of carrier concentration, total cell number was fixed at 2.5 × 10 6 cells/mL, thus this corresponded to 138 seeding densities of 1000, 1666 and 5000 cells/carrier. This led to a randomized 18-run design which included several 139 replicated runs to assess for lack-of-fit (Table S8 ). T cells were expanded for 14 d using these conditions to modify 140 the expansion process used before.
141
While there was a wide range of fold changes across all input parameters (Fig. 4a) , all runs appeared to generate 142 cells that were greater than 90 % viable when measured using acridine orange/propidium iodide (AO/PI) stain three main effects seem to influence the number of CD4 T cells with little interaction or quadratic effects (Fig. 4d ).
148
We further investigated the presence of interaction effects in the memory cell response (Fig. 4e ) and noted that there 149 appeared to be interaction between IL2 and carrier concentration (e.g. the slope of one is dependent on the other).
150
To verify the presence of these qualitative observations in each plot, we produced a model using stepwise linear 151 regression with Akaike information criteria (AIC) as the selection criteria ( we found a significant negative interaction effect between carrier concentration and mAb surface density, indicating 157 that there may be antagonism between these two parameters. Using the equation from this model, we calculated 158 the optimum settings for achieving high memory cell yield to be high IL2 (30 U/mL), mid carrier concentration
159
(1500 carriers/mL), and high mAb surface density (approx. 2000 mAbs/µm 2 ). For the CD4 response, only the main 160 effects were found significant and all were positively correlated with CD4 cell yield. In this case the optimum settings 161 were simply the high settings for each input (30 U/mL IL2, 2500 carriers/mL, and approx. 2000 mAbs/µm 2 ).
162
We also performed non-linear symbolic regression analysis to compliment the stepwise linear regression. This was showed good fit and minimal residual correlation (Figs. S7, S8b, S9b and S10b). Additionally, we plotted the 173 memory and CD4+ T cell yield at the optimal memory settings, and observed a trade-off of the yield between these 174 two subtypes as a function of carrier concentration (Fig. 5c ). The optimum setting results from both linear and 175 symbolic regression are summarized in Table 2 . beads, and thus could facilitate these larger contact areas. Third, the carriers may allow the T cells to cluster more 229 densely compared to beads, as evidenced by the large clusters on the outside of the carriers (Fig. 1f) higher memory cell formation.
176
234
An important aspect to our study was the inclusion of a DOE, which is used in many other non-biological 235 disciplines for process development. We specifically used this strategy here to optimize three process variables optimal set of conditions that can be used to produce higher numbers of T cells in practice, the surprising findings 256 also generated interesting hypotheses that may lead to better mechanistic understanding and further optimization.
257
These are undergoing further investigation.
258
In addition to obtaining better phenotypes, other advantages of our carrier approach are that the carriers are large 
263
It is important to note that all T cell cultures in this study were performed up to 14 days. Others have demon- in a 5 day culture. We should also note that we investigated one memory subtype (CCR7+CD62L+) in this study.
268
Future work will focus on other memory subtypes such as tissue resident memory and stem memory T cells, as well 269 as the impact of using the microcarrier system on the generation of these subtypes.
270
Another advantage is that the carrier system appears to induce a faster growth rate of T cells given the same
271
IL2 concentration compared to beads (Fig. 3) system will likely serve as a drop-in substitution to provide these benefits.
288
Conclusions
289
In summary, we have developed an in vivo-inspired T cell expansion system using porous, degradable, gelatin micro-290 carriers functionalized with anti-CD3 and anti-CD28 mAbs. Using this system, we have shown that we can achieve 291 higher frequencies of clinically-relevant memory and CD4+ T cell phenotypes compared to traditional bead-based 292 approaches. Additionally, we have shown that they still achieve greater fold change and memory T cell yield beads at 293 low-IL2 concentrations (20 U/mL), and that they can generate functional CAR T cells using lentiviral transduction 294 methods. This system is highly applicable to current T cell manufacturing processes where it may be used to provide
295
higher quality immunotherapies at a reduced reagent cost.
296
sterile ultrapure water and 7.5 µL SNB /mL PBS was added to carrier suspension and allowed to react for 60 min. After 302 washing the carriers three times in sterile PBS, 40 µg/mL STP (Jackson Immunoresearch) was added and allowed
303
to react for 60 min. After the reaction, supernatent was taken for the binding assay, and the carriers were washed 304 twice using sterile PBS. Biotinylated mAbs against human CD3 and CD28 were combined in a 1:1 mass ratio and 305 added to the carriers at 2 µg mAbs /mg carriers . In the case of the DOE experiment where variable mAb surface density 306 was utilized, the anti-CD3/anti-CD28 mAb mixture was further combined with a biotinylated isotype control to 307 reduce the overall fraction of targeted mAbs (for example the 60 % mAb surface density corresponded to 3 mass 308 parts anti-CD3, 3 mass parts anti-CD8, and 4 mass parts isotype control). mAbs were allowed to bind to the carriers 309 for 60 min. All mAbs were low endotoxin azide free (Biolegend custom, LEAF specification). Carriers were washed 310 in sterile PBS and washed once again in the cell culture media to be used for the T cell expansion. The concentration 311 of the final carrier suspension was found by taking a 50 µL sample, plating in a well, and imaging the entire well.
312
The image was then manually counted to obtain a concentration.
313
Microcarrier Quality Control Assays
314
STP and mAb binding to the carriers was quantified indirectly using a bicinchoninic acid assay (BCA) kit (Thermo
315
Fisher) according to the manufacture's instructions, with the exception that the standard curve was made with 316 known concentrations of purified STP or IgG instead of bovine serum albumin (BSA). Absorbance at 592 nm was 317 quantified using a Biotek plate reader.
318
Open biotin binding sites on the carriers after STP coating was quantified indirectly using FITC-biotin (Thermo transformations), and lack-of-fit tests where replicates were present (to assess model fit in the context of pure error).
371
Statistical significance was evaluated at α = 0.05.
372
For the DOE analysis, the design matrix was created using JMP 13.1 (SAS) with the custom design tool using
373
I-optimal criterion (to minimize prediction variance) and 4 replicates with 2 center points. The experiment was 374 analyzed using linear regression techniques (as described above).
375
All summary tables were generated using the stargazer package in R [60].
376
Flow Cytometry Antibodies
377
All mAbs used for flow cytometry are outlined in Table S11 .
378
Symbolic Regression
379
Symbolic regression was done using Evolved Analytics' DataModeler software. DataModeler uses genetic program-380 ming to evolve many symbolic regression models, and then selects the fittest models defined as those with the best 381 trade-off of R 2 (fit) and complexity (this selection accomplished via a pareto front and identifying models at the 382 knee). The collection of fittest models forms a diverse ensemble; the models in the ensemble will agree at observed 383 data points but diverge in extrapolated parameter spaces, providing a trust metric. Feature selection can also be 384 achieved by investigating which variables are present in the fittest models within the ensemble. 
